338 related articles for article (PubMed ID: 35617250)
1. Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia.
Sendekie AK; Teshale AB; Tefera YG
PLoS One; 2022; 17(5):e0268639. PubMed ID: 35617250
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemic events and glycemic control effects between NPH and premixed insulin in patients with type 2 diabetes mellitus: A real-world experience at a comprehensive specialized hospital in Ethiopia.
Sendekie AK; Netere AK; Belachew EA
PLoS One; 2022; 17(9):e0275032. PubMed ID: 36149907
[TBL] [Abstract][Full Text] [Related]
3. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
[TBL] [Abstract][Full Text] [Related]
4. A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin.
Raccah D; Chou E; Colagiuri S; Gaàl Z; Lavalle F; Mkrtumyan A; Nikonova E; Tentolouris N; Vidal J; Davies M
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27606888
[TBL] [Abstract][Full Text] [Related]
5. Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study.
Sendekie AK; Belachew EA; Dagnew EM; Netere AK
BMJ Open; 2022 Sep; 12(9):e065250. PubMed ID: 36691186
[TBL] [Abstract][Full Text] [Related]
6. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study.
Zhang B; Zhao J; Yang W;
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667797
[TBL] [Abstract][Full Text] [Related]
7. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
Lipska KJ; Parker MM; Moffet HH; Huang ES; Karter AJ
JAMA; 2018 Jul; 320(1):53-62. PubMed ID: 29936529
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of type 2 diabetes patients with discordance between HbA
Shu H; Lu J; Zhang P; Zhu D; Li X; Ji J; Zhao F; Ji L
Diabetes Metab Res Rev; 2018 May; 34(4):e2977. PubMed ID: 29314667
[TBL] [Abstract][Full Text] [Related]
9. Determinants of glycemic control among insulin treated diabetic patients in Southwest Ethiopia: hospital based cross sectional study.
Angamo MT; Melese BH; Ayen WY
PLoS One; 2013; 8(4):e61759. PubMed ID: 23620789
[TBL] [Abstract][Full Text] [Related]
10. Comparative study between two recombinant human NPH insulin formulations for the treatment of type 2 diabetes mellitus.
Rassi N; Moraes SM; Alves AG; Cavalheiro DC; Moreira JM; Bellório KB; Abreu FC; Prata PR; Teixeira Lde S; Rassi S
Arch Endocrinol Metab; 2016 Feb; 60(1):47-53. PubMed ID: 26909482
[TBL] [Abstract][Full Text] [Related]
11. Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real-world data.
Peng Y; Xu P; Shi J; Zhang Y; Wang S; Zheng Q; Wang Y; Ke T; Li L; Zhao D; Dai Y; Dong Q; Ji B; Xu F; Gu W; Wang W
J Diabetes; 2022 Feb; 14(2):134-143. PubMed ID: 35023626
[TBL] [Abstract][Full Text] [Related]
12. Glycemic control and its associated factors among adult diabetic patients in Southern Ethiopia: a cross-sectional study.
Abose A; Getachew A; Obsa F; Bekele S; Haile K; Abose S
Afr Health Sci; 2024 Mar; 24(1):187-197. PubMed ID: 38962352
[TBL] [Abstract][Full Text] [Related]
13. Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: a case control study.
Mamo Y; Bekele F; Nigussie T; Zewudie A
BMC Endocr Disord; 2019 Aug; 19(1):91. PubMed ID: 31464602
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.
Mata-Cases M; Mauricio D; Franch-Nadal J
J Diabetes; 2017 Jan; 9(1):34-44. PubMed ID: 26749415
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
Halimi S; Raskin P; Liebl A; Kawamori R; Fulcher G; Yan G
Clin Ther; 2005; 27 Suppl B():S57-74. PubMed ID: 16519038
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study comparing neutral protamine hagedorn insulin with glargine as basal therapy in prednisone-associated diabetes mellitus in hospitalized patients.
Dhital SM; Shenker Y; Meredith M; Davis DB
Endocr Pract; 2012; 18(5):712-9. PubMed ID: 22784834
[TBL] [Abstract][Full Text] [Related]
17. Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).
Gao L; Zhang P; Weng J; Lu J; Guo X; Jia W; Yang W; Zou D; Zhou Z; Pan C; Gao Y; Li X; Zhu D; Wu Y; Garg SK; Ji L
J Diabetes; 2020 Sep; 12(9):668-676. PubMed ID: 32329194
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fasting capillary glucose variability between insulin glargine and NPH.
Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L
Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study.
Abera RG; Demesse ES; Boko WD
BMC Endocr Disord; 2022 Mar; 22(1):54. PubMed ID: 35249547
[TBL] [Abstract][Full Text] [Related]
20. Effect of gender on treatment outcomes in type 2 diabetes mellitus.
McGill JB; Vlajnic A; Knutsen PG; Recklein C; Rimler M; Fisher SJ
Diabetes Res Clin Pract; 2013 Dec; 102(3):167-74. PubMed ID: 24183259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
